When Does Medical Software Qualify as a Medical Device? | MDR & IVDR Guide

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Understanding when software qualifies as a medical device is crucial to ensuring compliance with EU regulations — and ultimately, patient safety.

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Guide

The rapid adoption of digital health solutions has brought software to the forefront of medical and healthcare applications. However, not all health-related software qualifies as a medical device. This guide explores when software is classified as Medical Device Software (MDSW) under Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR). It breaks down classification frameworks, key guidelines, and risk-based classification rules to support medical software manufacturers in navigating compliance requirements.

 

Key Topics Covered

  • Overview of MDR and IVDR regulations
  • IMDRF guidance on Software as a Medical Device (SaMD)
  • Classification rules and risk categories
  • Practical examples of software qualification
  • Comparison with FDA software regulations

Unlock critical insights into medical software qualification and ensure your software meets EU regulatory standards, Download the guide now

 

Hero Image Medical Software as MD Guide MedTech

View our other resources and company news

GMP Raising the bar Blog series Header image May 25 Blog

EMA vs USFDA: AI Compliance in GxP Pharma Environments

With AI reshaping pharma, global firms must align with both EMA and USFDA guidance. This article unpacks the regulatory differences and offers practical tips for ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

EMA Draft Revisions to EU GMP: Annex 11, Annex 22 & AI

The EMA has launched public consultation on major EU GMP updates, including new requirements for AI, documentation, and computerised systems. Here’s what pharma and biotech ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Understanding ALCOA+ and Data Integrity in GxP Compliance

Data integrity is central to regulatory compliance in pharma and biotech. Discover how ALCOA and ALCOA+ principles help organisations uphold GxP standards—and how Rephine supports ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

GxP Compliance in Emerging Markets

Emerging markets face unique regulatory challenges in maintaining pharmaceutical quality and safety. Learn how GxP compliance, third-party GMP audits, and digital tools from Rephine support ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Sustainable Auditing in Pharma: Eco-Friendly GxP & GMP Compliance

As ESG targets grow more critical, pharma firms are rethinking audit models. Explore how sustainable auditing helps cut emissions while ensuring compliance.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Building Resilient Pharmaceutical Supplier Ecosystems

In today's volatile landscape, traditional supplier qualification is no longer enough. Learn how pharma companies can build resilient supplier ecosystems through risk-based strategies, real-time monitoring, ...
Read More
CPV Header image blog apr 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

IT Quality Assurance plays a pivotal role in the life sciences sector, ensuring systems are validated, compliant, and audit-ready. Learn how pharma companies can meet ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

Artificial intelligence and data analytics are reshaping pharmaceutical GMP compliance—but not all innovations are audit-ready. This article explores proven AI use cases, regulator expectations, and ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Risk-Based Auditing: Smarter GxP Compliance with Limited Resources

In today’s pharma landscape, risk-based auditing enables smarter supplier oversight by aligning audit efforts with risk. Discover the benefits, regulatory backing, and how Rephine helps ...
Read More
Contact Us